Literature DB >> 1941757

Plasma taurine concentrations and M-mode echocardiographic measures in healthy cats and in cats with dilated cardiomyopathy.

D D Sisson1, D H Knight, C Helinski, P R Fox, B R Bond, N K Harpster, N S Moise, P M Kaplan, J D Bonagura, G Czarnecki.   

Abstract

M-mode echocardiography was completed and plasma taurine concentrations were determined in 79 healthy cats and 77 cats with dilated cardiomyopathy (DCM). In healthy cats, a relationship was not observed between plasma taurine concentrations and any M-mode echocardiographic measurement. End-systolic and end-diastolic cardiac chamber dimensions were larger; wall thickness measures were smaller; and calculations of fractional shortening were less in cats with DCM than in healthy cats. Plasma taurine concentrations less than 30 nmol/mL were detected in 7/79 healthy cats and in 52/77 cats with DCM. Of the 52 cats with DCM and an initial plasma taurine concentration less than 30 nmol/mL, 23 died or were euthanized during the first post-treatment week, 7 were lost to further study, and 22 improved after taurine supplementation. Of the 25 cats with DCM and an initial plasma taurine concentration greater than or equal to 30 nmol/mL, 9 died or were euthanatized during the first post-treatment week, and 9 were lost to further study. Two cats did not improve, of which one died and one was euthanatized 4 to 8 weeks after initiation of taurine supplementation. Five cats with a plasma taurine concentration greater than or equal to 30 nmol/mL improved after taurine supplementation. Myocardial function subsequently deteriorated in three of these cats. Two of the three cats had signs of congestive heart failure redevelop.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941757     DOI: 10.1111/j.1939-1676.1991.tb00954.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  8 in total

1.  Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study.

Authors:  Mylène Taillefer; Rocky Di Fruscia
Journal:  Can Vet J       Date:  2006-05       Impact factor: 1.008

2.  Dilated cardiomyopathy with endocardial fibroelastosis in a juvenile Pallas cat.

Authors:  Erwin K Gudenschwager; Jonathan A Abbott; Tanya LeRoith
Journal:  J Vet Diagn Invest       Date:  2019-01-29       Impact factor: 1.279

3.  Echocardiographic evidence for myocardial failure induced by taurine deficiency in domestic cats.

Authors:  M J Novotny; P M Hogan; G Flannigan
Journal:  Can J Vet Res       Date:  1994-01       Impact factor: 1.310

4.  Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.

Authors:  Gabriel Wurtinger; Estelle Henrich; Nicolai Hildebrandt; Nicola Wiedemann; Matthias Schneider; Esther Hassdenteufel
Journal:  BMC Vet Res       Date:  2017-12-20       Impact factor: 2.741

5.  Comparative assessment of left atrial volume in healthy cats by two-dimensional and three-dimensional echocardiography.

Authors:  Janina Rauch; Michael Fehr; Martin Beyerbach; Stephan O Hungerbuehler
Journal:  BMC Vet Res       Date:  2020-07-29       Impact factor: 2.741

6.  Dilated cardiomyopathy in juvenile Portuguese Water Dogs.

Authors:  Margaret M Sleeper; Paula S Henthorn; C Vijayasarathy; Donna M Dambach; Tim Bowers; Pierre Tijskens; Clara F Armstrong; Edward B Lankford
Journal:  J Vet Intern Med       Date:  2002 Jan-Feb       Impact factor: 3.333

7.  Echocardiographic findings in 11 cats with acromegaly.

Authors:  J A Myers; K F Lunn; J M Bright
Journal:  J Vet Intern Med       Date:  2014-06-24       Impact factor: 3.333

8.  Effect of Body Weight on Echocardiographic Measurements in 19,866 Pure-Bred Cats with or without Heart Disease.

Authors:  J Häggström; Å O Andersson; T Falk; L Nilsfors; U OIsson; J G Kresken; K Höglund; M Rishniw; A Tidholm; I Ljungvall
Journal:  J Vet Intern Med       Date:  2016-08-30       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.